Martek to Present at 11th Annual ICR XChange

Friday, January 9, 2009 General News
Email Print This Page Comment bookmark
Font : A-A+

COLUMBIA, Md., Jan. 8 Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will be presenting at the upcoming 11th Annual ICR XChange investor conference. The conference is being held January 14-15, 2009 at The St. Regis Monarch Beach Resort & Spa in Dana Point, California. Peter L. Buzy, Chief Financial Officer, and David Abramson, President, will be presenting on Wednesday January 14, 2009 at 1:25 PM PT.



A live audio webcast of Martek's presentation can be accessed at: http://investor.shareholder.com/icr/eventdetail.cfm?eventid=64032



Martek Biosciences Corporation is a leader in the innovation and development of omega-3 DHA products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a vegetarian source of the omega-3 fatty acid DHA (docosahexaenoic acid), for use in foods, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.





Contact: Kyle Stults Investor Relations (410) 740-0081

SOURCE Martek Biosciences Corporation


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook